GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma

Luhao Li1, Suxin Li1, Haohao Wang1

  • 1Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, Henan, 450052, China.

Abstract

Insights

Homo-sapiens histone H3 associated protein kinase (GSG2) is overexpressed in hepatocellular carcinoma (HCC). Knocking down GSG2 inhibits HCC progression and tumor growth, suggesting GSG2 plays an oncogenic role in HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide.
  • Targeted therapies are improving survival rates in cancer patients.
  • The specific role of homo-sapiens histone H3 associated protein kinase (GSG2) in HCC remains unclear.

Purpose of the Study:

  • To investigate the expression and function of GSG2 in hepatocellular carcinoma.
  • To determine the impact of GSG2 on HCC cell proliferation, apoptosis, and tumor growth.
  • To elucidate the potential oncogenic role of GSG2 in HCC development.

Main Methods:

  • Immunohistochemical staining to detect GSG2 expression in HCC tissues.
  • GSG2 knockdown using lentivirus-mediated short hairpin RNA (shRNA) in HCC cell lines.
  • In vitro assays (MTT, colony formation, flow cytometry) and in vivo mice xenograft model to assess tumor growth and apoptosis.
  • Human Apoptosis Antibody Array to explore underlying mechanisms.

Main Results:

  • GSG2 was significantly overexpressed in HCC tissues compared to adjacent normal tissues.
  • GSG2 knockdown inhibited HCC cell proliferation and colony formation in vitro.
  • GSG2 knockdown promoted apoptosis, evidenced by increased caspase 3, caspase 8, Fas, and FasL expression, and decreased IGF1, Bcl2, and Bcl-w.
  • Inhibition of GSG2 suppressed tumor growth in vivo.

Conclusions:

  • GSG2 knockdown effectively suppresses tumor growth in both in vitro and in vivo models of HCC.
  • GSG2 appears to play a crucial oncogenic role in the progression of hepatocellular carcinoma.
  • Targeting GSG2 may represent a potential therapeutic strategy for HCC treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K